A new blood test capable of detecting more than 50 types of cancer has delivered highly promising results in one of the largest interventional screening trials to date. The PATHFINDER 2 study of the Galleri multi-cancer early detection (MCED)…
A new blood test capable of detecting more than 50 types of cancer has delivered highly promising results in one of the largest interventional screening trials to date. The PATHFINDER 2 study of the Galleri multi-cancer early detection (MCED)…